The Secret Life of NAD+: An Old Metabolite Controlling New Metabolic Signaling Pathways
Open accessThe DOI matches its Crossref record; 250 of the 251 references it cites were found in a registry or an index.
Abstract
A century after the identification of a coenzymatic activity for NAD+, NAD+ metabolism has come into the spotlight again due to the potential therapeutic relevance of a set of enzymes whose activity is tightly regulated by the balance between the oxidized and reduced forms of this metabolite. In fact, the actions of NAD+ have been extended from being an oxidoreductase cofactor for single enzymatic activities to acting as substrate for a wide range of proteins. These include NAD+-dependent protein deacetylases, poly(ADP-ribose) polymerases, and transcription factors that affect a large array of cellular functions. Through these effects, NAD+ provides a direct link between the cellular redox status and the control of signaling and transcriptional events. Of particular interest within the metabolic/endocrine arena are the recent results, which indicate that the regulation of these NAD+-dependent pathways may have a major contribution to oxidative metabolism and life span extension. In this review, we will provide an integrated view on: 1) the pathways that control NAD+ production and cycling, as well as its cellular compartmentalization; 2) the signaling and transcriptional pathways controlled by NAD+; and 3) novel data that show how modulation of NAD+-producing and -consuming pathways have a major physiological impact and hold promise for the prevention and treatment of metabolic disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“they also oxidize the cytosolic NAD +/NADH pool through the α-glycerophosphate and malate-aspartate shuttles”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Houtkooper et al., 2010
In the citing paper
“Through SIRTss, NAD+ provides a direct link between the cellular energy state of the cell and control of signaling and transcriptional events [reviewed in Houtkooper et al. (258)].”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [258]
Citations
Cites
4 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedRETRACTED: Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex
Zhang, Q., Wang, S.-Y., Fleuriel, C., Leprince, D., Rocheleau, J. V., Piston, D. W., & Goodman, R. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610590104 · Cited by 171 · cited 2×
“This increase was associated with SIRT1 activation, whereas other SIRTs were unaffected (180).”
BackgroundRetractedRETRACTED: Nicotinamide nucleotide transhydrogenase: A key role in insulin secretion
Freeman, H. C., Shimomura, K., Horner, E., Cox, R., & Ashcroft, F. M. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.008 · Cited by 157
RetractedFukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2007) · Science · doi:10.1126/science.318.5850.565b · Cited by 150
RetractedMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 1×
“Another link between neurodegeneration and NAD metabolism lies in the fact that many neurodegenerative disorders, including Parkinson’s, Alzheimer’s, and Huntington’s disease, have been tightly linked to mitochondrial dysfunction, notably the generation of reactive oxygenspecies(222).”
BackgroundResveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290 · cited 2×
“Increasing SIRT1 activity, by using pharmacological levels of resveratrol, prevented the development of diet-induced obesity and the concurrent metabolic disease in mice (101, 206).”
BackgroundLagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057 · cited 3×
“The relevance of SIRT1 in the control of whole body glucose homeostasis is the result of the combined action on different tissues (101, 102), and it has a critical role during fasting (103).”
BackgroundSelf-citationSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796 · cited 1×
“Supporting this hypothesis, several studies indicated that Sir2 could be a critical mediator of the beneficial effects of calorie restriction (CR) on yeast life span (61, 62).”
BackgroundTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510 · cited 1×
“Enzymes Km for NAD Sir2 100 M (242) SIRT1 150–200 M (243) SIRT2 100 M (243) SIRT3 280 M (244) SIRT4 Unknown SIRT5 Unknown SIRT6 Unknown SIRT7 Unknown PARP1 20–60 M (245, 246) PARP2 130 M (246) CD38 15–25 M (85, 153, 247) Endocrine Reviews, April 2010, 31(2):194–223 edrv.”
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · cited 4×
“This AMPK-induced increase in NAD was associated with an increase in SIRT1-mediated PGC-1 deacetylation and subsequent activation of oxidative mitochondrial activity (83).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 1
- Warburg, 1935, Wasserstoffübertragendes Co-Ferment, seine Zusammensetzung und Wirkungsweise., Biochem Z, 282, 157
Cited by
Items 301–400 of 949
Improving the description of metabolic networks: the TCA cycle as example
Stobbe, M. D., Houten, S. M., van Kampen, A. H. C., Wanders, R. J. A., & Moerland, P. D. (2012) · The FASEB Journal · doi:10.1096/fj.11-203091 · Cited by 62
Self-citationmTOR may interact with PARP-1 to regulate visible light-induced parthanatos in photoreceptors
Pan, Y.-R., Song, J., Fan, B., Wang, Y., Che, L., Zhang, S., Chang, Y., He, C., & Li, G. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-019-0498-0 · Cited by 52
Vettraino, M., Manerba, M., Govoni, M., & Stefano, G. D. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328363ae50 · Cited by 54
The sirtuins: Markers of metabolic health
Covington, J. D., & Bajpeyi, S. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500340 · Cited by 54
SIRT1 — a metabolic sensor that controls blood vessel growth
Guarani, V., & Potente, M. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.01.001 · Cited by 52
NAMPT-Mediated Salvage Synthesis of NAD+ Controls Morphofunctional Changes of Macrophages
Venter, G., Oerlemans, F. T. J. J., Willemse, M., Wijers, M., Fransen, J. A. M., & Wieringa, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097378 · Cited by 51
“Although the biosynthetic pathways involved in the synthesis of NAD(H) and NADP(H) are generally quite well conserved in mammalian cells, their synthetic capacity and also the intracellular levels of NAD(H) and NADP(H) may differ dramatically between cell types [21,61].”
BackgroundThe potential regulatory roles of NAD+ and its metabolism in autophagy
Zhang, D., Zhang, J.-P., Hu, J., & Huang, Y. (2015) · Metabolism · doi:10.1016/j.metabol.2015.11.010 · Cited by 54
Owens, K., Park, J. H., Schuh, R. A., & Kristián, T. (2013) · Translational Stroke Research · doi:10.1007/s12975-013-0278-x · Cited by 52
“tryptophan are localized in the cytosol [84].”
Association of Human Whole Blood NAD+ Contents With Aging
Yang, F., Deng, X., Yu, Y., Luo, L., Chen, X., Zheng, J., Qiu, Y., Xiao, F., Xie, X., Zhao, Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.829658 · Cited by 54
Inefficient Batteries in Heart Failure
Schwartz, B., Gjini, P., Gopal, D. M., & Fetterman, J. L. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.03.017 · Cited by 55
Moore, T. M., Cheng, L., Wolf, D. M., Ngo, J., Segawa, M., Zhu, X., Strumwasser, A. R., Cao, Y., Clifford, B. L., Ma, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34468-2 · Cited by 54
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
Bhasin, S., Seals, D. R., Migaud, M. E., Musi, N., & Baur, J. A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad019 · Cited by 55
Interference between PARPs and SIRT1: a novel approach to healthy ageing?
Cantó, C., & Auwerx, J. (2011) · Aging · doi:10.18632/aging.100326 · Cited by 50
“SIRT1 activity can be controlled by the regulation of its expression, by some post-translational modifications and, interestingly, by NAD levels [5].”
BackgroundSelf-citationThe Peroxisomal NAD Carrier from Arabidopsis Imports NAD in Exchange with AMP
van Roermund, C. W. T., Schroers, M. G., Wiese, J., Facchinelli, F., Kurz, S., Wilkinson, S., Charton, L., Wanders, R. J. A., Waterham, H. R., Weber, A. P. M., et al. (2016) · Plant Physiology · doi:10.1104/pp.16.00540 · Cited by 48
“Furthermore, NAD is also a precursor for cADP-ribose, which modulates the release of calcium as a second messenger (Pollak et al., 2007; Houtkooper et al., 2010).”
BackgroundSelf-citationBagga, P., Hariharan, H., Wilson, N. E., Beer, J. C., Shinohara, R. T., Elliott, M. A., Baur, J. A., Marincola, F. M., Witschey, W. R. T., Haris, M., et al. (2019) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27971 · Cited by 50
“7 ppm, 8 averages), and (3) NAD+ acquisition (TR = 1 s, excitation”
Hydrogen Attenuates Allergic Inflammation by Reversing Energy Metabolic Pathway Switch
Niu, Y., Nie, Q., Dong, L., Zhang, J., Liu, S. F., Song, W., Wang, X., Wu, G. C., & Song, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-58999-0 · Cited by 50
Zheng, X., Bair, K. W., Bauer, P., Baumeister, T., Bowman, K. K., Buckmelter, A. J., Caligiuri, M., Clodfelter, K. H., Feng, Y., Han, B., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.074 · Cited by 49
Schuster, S., Penke, M., Gorski, T., Petzold-Quinque, S., Damm, G., Gebhardt, R., Kiess, W., & Garten, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091045 · Cited by 44
“NAD is required for both processes [19] and regulates crucial biological processes, including transcription, cell cycle progression, DNA repair and metabolic pathways [20,21].”
New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity
Oh, G., Kim, H., Shen, A., Lee, S., Yang, S., Shim, H., Cho, E. Y., Kwon, K., Kwak, T. H., & So, H. (2016) · BioMed Research International · doi:10.1155/2016/4048390 · Cited by 55
“In this review,we describe the role ofNAD+metabolism in cisplatininduced nephrotoxicity and discuss a potential strategy for the prevention or treatment of cisplatin-induced adverse effects with a particular focus on NAD+-dependent cellular pathways.”
BackgroundPellicciari, R., Liscio, P., Giacchè, N., De Franco, F., Carotti, A., Robertson, J., Cialabrini, L., Katsyuba, E., Raffaelli, N., & Auwerx, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01254 · Cited by 45
Self-citationNicotinamide N-methyltransferase as a potential marker for cancer
Lu, X., & Long, H. (2018) · Neoplasma · doi:10.4149/neo_2018_171024n680 · Cited by 49
Logan, R. W., Parekh, P. K., Kaplan, G. N., Becker-Krail, D. D., Williams, W. P., Yamaguchi, S., Yoshino, J., Shelton, M. A., Zhu, X., Zhang, H., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0061-1 · Cited by 48
“NADH, both of which respond to cellular energy demands and redox state [27].”
Juszczak, F., Arnould, T., & Declèves, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136936 · Cited by 48
“Based on their K m values, sirtuins are strongly dependent on NAD + availability when compared to other NAD + -dependent enzymes such as PARPs and CD38 [49].”
BackgroundAudrito, V., Managò, A., Gaudino, F., & Deaglio, S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.001 · Cited by 51
“By modulating NAD+-metabolizing enzymes, NAD controls key processes, including energy metabolism and cell survival [35,36].”
BackgroundSwitch of NAD Salvage to de novo Biosynthesis Sustains SIRT1-RelB-Dependent Inflammatory Tolerance
Zhang, J., Tao, J., Ling, Y., Li, F., Zhu, X., Xu, L., Wang, M., Zhang, S., McCall, C. E., & Liu, T. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02358 · Cited by 48
Healthy ageing and Mediterranean diet: A focus on hormetic phytochemicals
Alì, S., Davinelli, S., Accardi, G., Aiello, A., Caruso, C., Duro, G., Ligotti, M. E., Pojero, F., Scapagnini, G., & Candore, G. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111592 · Cited by 51
Afzaal, A., Rehman, K., Kamal, S., & Akash, M. S. H. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23047 · Cited by 50
Song, T., Yang, L., Kabra, N., Chen, L., Koomen, J. M., Haura, E. B., & Chen, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.470302 · Cited by 48
McCormack, S., Polyak, E., Ostrovsky, J., Dingley, S. D., Rao, M., Kwon, Y. J., Xiao, R., Zhang, Z., Nakamaru-Ogiso, E., & Falk, M. J. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.02.005 · Cited by 45
“As resveratrol is not a direct precursor for NAD+, its effects could reflect NAD+ salvage rather than increased de novo biosynthesis (Houtkooper et al, 2010; Pittelli et al, 2010) (Figure 8).”
BackgroundPacella‐Ince, L., Zander‐Fox, D., & Lane, M. (2013) · Reproduction Fertility and Development · doi:10.1071/rd13178 · Cited by 50
The hallmarks of aging in Ataxia-Telangiectasia
Aguado, J., Gómez‐Inclán, C., Leeson, H. C., Lavin, M. F., Shiloh, Y., & Wolvetang, E. J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101653 · Cited by 49
“The sirtuins are a family of NAD-dependent protein deacetylases and ADPribosyltransferases that sense low-energy states by detecting high NAD+ levels (Houtkooper et al., 2010).”
Chan, M., Gravel, M., Bramoullé, A., Bridon, G., Avizonis, D., Shore, G. C., & Roulston, A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0809 · Cited by 46
“As a cellular response to DNA damage, PARP is activated and consumes its substrate NADþ for the poly-(ADP-ribosylation) (PAR) of proteins (3).”
BackgroundMitochondrion as a Target for Heart Failure Therapy – Role of Protein Lysine Acetylation –
Lee, C. F., & Tian, R. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0742 · Cited by 54
Lucena-Cacace, A., Umeda, M., Navas, L. E., & Carnero, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00292 · Cited by 49
Maintenance of NAD+ Homeostasis in Skeletal Muscle during Aging and Exercise
Ji, L. L., & Yeo, D. (2022) · Cells · doi:10.3390/cells11040710 · Cited by 40
“This reaction fulfills an important role in DNA repair at the damaging site and maintains proper genomic integrity [29].”
BackgroundInfluentialACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH
Liu, Y. J., Kimura, M., Li, X., Sulc, J., Wang, Q., Rodríguez-López, S., Scantlebery, A. M. L., Strotjohann, K., Gallart‐Ayala, H., Vijayakumar, A., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.009 · Cited by 48
“15,16 Furthermore, NAD + is also a co-substrate for non-redox enzymes, including poly (ADP-ribose) polymerases (PARPs), sirtuins, and ectonucleotidases, affecting essential processes such as metabolic fitness, DNA damage repair, and immune and inflammatory processes.”
Self-citationWhite, A. T., McCurdy, C. E., Philp, A., Hamilton, D. L., Johnson, C. D., & Schenk, S. (2013) · Diabetologia · doi:10.1007/s00125-013-2912-2 · Cited by 50
“The therapeutic potential of SIRT1 activation for the treatment of muscle insulin resistance has been proposed for some years [2, 3].”
NAD+ in Cancer Prevention and Treatment: Pros and Cons
Poljšak, B. (2016) · Journal of Clinical & Experimental Oncology · doi:10.4172/2324-9110.1000165 · Cited by 48
“Both human and mouse SIRT1 are thought to promote cell survival by deacetylating and thus deactivating p53 tumour suppressor gene hence enhancing p53 degradation [59,60].”
BackgroundAspects of Tryptophan and Nicotinamide Adenine Dinucleotide in Immunity: A New Twist in an Old Tale
Biefer, H. R. C., Vasudevan, A., & Elkhal, A. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917713491 · Cited by 47
Cheng, J., Liu, C., Hu, K., Greenberg, A. S., Wu, D., Ausman, L. M., McBurney, M. W., & Wang, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.004 · Cited by 47
Resident bacteria contribute to opportunistic infections of the respiratory tract
Wu, Y., Wang, Y., Yang, H., Li, Q., Gong, X., Zhang, G., & Zhu, K. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009436 · Cited by 48
“Normally, the abundance of NAD in the respiratory tract of healthy individuals is insufficient for their survival and growth [11–13] because the limited resource of NAD is subtly modulated by hosts to maintain homeostasis [13, 14].”
BackgroundPyrazinamide: the importance of uncovering the mechanisms of action in mycobacteria
Stehr, M., Elamin, A. A., & Singh, M. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1021784 · Cited by 45
“NAD can rapidly be consumed by several NADconsuming enzymes (NAD-dependent DNA ligase, mono (ADP-ribosyl) transferase, sirtuin-like proteins, and RNA 2’-phosphotransferases) to finally generate nicotinamide as the most common end-product [52,92–98].”
BackgroundVareki, S. M., Chen, D., Cresce, C. D., Ferguson, P. J., Figueredo, R., Pampillo, M., Rytelewski, M., Vincent, M. D., Min, W., Zheng, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143435 · Cited by 48
“IDO expression also increases intracellular NAD levels required for PARP and BER activity [31].”
BackgroundNicotinamide N-Oxidation by CYP2E1 in Human Liver Microsomes
Real, A. M., Hong, S., & Pissios, P. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.049734 · Cited by 44
“It is a precursor for nicotinamide adenine dinucleotide, which is best known as an electron carrier in oxidative phosphorylation and as a cofactor for many dehydrogenases (Bogan and Brenner, 2008; Houtkooper et al., 2010).”
BackgroundHormones, Metabolism and the Benefits of Exercise
(2017) · Research and Perspectives in Endocrine Interactions · doi:10.1007/978-3-319-72790-5 · Cited by 44
Current Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
Poljšak, B., Kovač, V., & Milisav, I. (2022) · Antioxidants · doi:10.3390/antiox11091637 · Cited by 52
Targeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle Wasting
Huot, J. R., Baumfalk, D. R., Resendiz, A., Bonetto, A., Smuder, A. J., & Penna, F. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0149 · Cited by 49
Giannetti, A. M., Zheng, X., Skelton, N. J., Wang, W., Bravo, B. J., Bair, K. W., Baumeister, T., Cheng, E., Crocker, L., Feng, Y., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4015108 · Cited by 44
Motyl, J. A., Wencel, P. L., Cieślik, M., Strosznajder, R. P., & Strosznajder, J. B. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0317-1 · Cited by 51
“The other NAD-regulated enzyme family (17 members) of PARPs, as compared to SIRTs, exhibits higher affinity to the βNAD particle [56, 57].”
BackgroundXia, N., Weisenburger, S., Koch, E., Burkart, M., Reifenberg, G., Förstermann, U., & Li, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13703 · Cited by 45
“NAMPT is the rate-limiting enzyme for NAD+ biosynthesis in the salvage pathway and in vivo studies demonstrate that NAMPT expression levels closely correlate with cellular NAD+ production (Houtkooper et al., 2010; Zhang and Kraus, 2010).”
BackgroundInfluentialRuan, Q., Ruan, J., Zhang, W., Qian, F., & Yu, Z. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.010 · Cited by 45
Perturbations in the p53/miR-34a/SIRT1 pathway in the R6/2 Huntington's disease model
Reynolds, R. H., Petersen, M. H., Willert, C. W., Heinrich, M., Nymann, N., Dall, M., Treebak, J. T., Björkqvist, M., Silahtaroglu, A., Hasholt, L., et al. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.12.009 · Cited by 46
Biomimetic Hydrogenation Catalyzed by a Manganese Model of [Fe]‐Hydrogenase
Pan, H., & Hu, X. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201914377 · Cited by 45
Ferrick, L., Lee, Y. S. L., & Gardner, D. K. (2020) · Human Reproduction · doi:10.1093/humrep/deaa181 · Cited by 45
Zhu, Z., Ding, Y., Wu, B., & Zhou, Y. (2020) · Chemical Science · doi:10.1039/d0sc04188b · Cited by 44
Xu, Y., Wang, J., Song, X., Wei, R., He, F., Peng, G., & Luo, B. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.11.007 · Cited by 46
Walker, M. A., Chen, H., Yadav, A. S., Ritterhoff, J., Villet, O. M., McMillen, T. S., Wang, Y., Purcell, H. J., Djukovic, D., Raftery, D., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.066039 · Cited by 43
“14 Previously, we have demonstrated that imbalanced NADH production and oxidation in mitochondria can be a positive regulator of pathological remodeling in failing hearts.”
BackgroundUnderstanding specific functions of PARP-2: new lessons for cancer therapy.
Ali, S. O., Khan, F. A., Galindo-Campos, M. A., & Yélamos, J. (2016) · RECERCAT (Consorci de Serveis Universitaris de Catalunya) · Cited by 61
Wencel, P. L., Lukiw, W. J., Strosznajder, J. B., & Strosznajder, R. P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0646-8 · Cited by 42
“enzyme in non-amyloidogenic processing of APP [71].”
Nguyen, L. T., Chen, H., Zaky, A. A., Pollock, C. A., & Saad, S. (2018) · The Journal of Physiology · doi:10.1113/jp276957 · Cited by 44
“SIRT1 activity strictly depends on the cellular availability of NAD+, which fluctuates in accordancewith the circadian rhythm and energy status (Houtkooper et al. 2010).”
BackgroundMulti-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism
Klimova, N., & Kristián, T. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02729-0 · Cited by 44
Ahmadi, A., Begue, G., Valencia, A. P., Norman, J., Lidgard, B., Bennett, B. J., Doren, M. V., Marcinek, D. J., Fan, S., Prince, D. K., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.167274 · Cited by 44
“A possible explanation for the enhanced carbohydrate utilization with NR supplementation is improved SIRT1 activity that directly regulates mitochondrial function and biogenesis through PGC-1α (25).”
Macro domains as metabolite sensors on chromatin
Marjanović, M. P., Timinszky, G., & Buschbeck, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1294-4 · Cited by 44
NAD+ Precursors: A Questionable Redundancy
Cantó, C. (2022) · Metabolites · doi:10.3390/metabo12070630 · Cited by 44
“In contrast, ARTD1 and CD38 show a very low Km for NAD+, suggesting that their activity is not generally bottlenecked by NAD+ content [7], unless a very sharp decline in NAD+ occurs.”
BackgroundInfluentialGunzner, J. L., Zhao, G., Bauer, P., Baumeister, T., Buckmelter, A. J., Caligiuri, M., Clodfelter, K. H., Fu, B., Han, B., Ho, Y., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.04.040 · Cited by 42
Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
Cercillieux, A., Ciarlo, E., & Cantó, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04499-5 · Cited by 42
“PARP1 is an avid NAD+ consumer, while some sirtuins, such as SIRT1, have a relatively high catalytic Km for NAD+ [10].”
BackgroundMethodInfluentialHistone malonylation is regulated by SIRT5 and KAT2A
Zhang, R., Bons, J., Scheidemantle, G. M., Liu, X., Bielska, O., Carrico, C., Rose, J., Heckenbach, I., Scheibye‐Knudsen, M., Schilling, B., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106193 · Cited by 47
“As a sirtuin family member, the deacylase activity of SIRT5 requires the availability of co-substrate NAD (Houtkooper et al., 2010).”
BackgroundPreyat, N., Rossi, M., Kers, J., Chen, L., Bertin, J., Gough, P. J., Moine, A. L., Rongvaux, A., Gool, F. V., & Léo, O. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.60 · Cited by 43
Sirtuin 1 in osteoarthritis: Perspectives on regulating glucose metabolism
Liao, Z., Cai, X., Zheng, Y., Lin, J., Yang, X., Lin, W., Zhang, Y., He, X., & Liu, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107141 · Cited by 47
Chiang, S.-H., Harrington, W. W., Luo, G., Milliken, N. O., Ulrich, J. C., Chen, J., Rajpal, D. K., Qian, Y., Carpenter, T., Murray, R., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134927 · Cited by 41
“expression, signaling, DNA repair and calcium homeostasis (reviewed in [1, 2]).”
BackgroundRole of PGC-1α in the Mitochondrial NAD+ Pool in Metabolic Diseases
Koh, J., & Kim, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094558 · Cited by 43
“Two NADH molecules produced in the cytosol by glycolysis are delivered into the mitochondrial matrix to provide reducing equivalents for the TCA cycle and ETC [13,48,68,69].”
BackgroundInfluentialCircadian regulated control of myocardial ischemia-reperfusion injury
Rabinovich-Nikitin, I., & Kirshenbaum, L. A. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.09.003 · Cited by 42
Terpenylated Coumarins As SIRT1 Activators Isolated from Ailanthus altissima
Đào, T. T., Tran, T.-L., Kim, J., Nguyen, P.-H., Lee, E. H., Park, J., Jang, I., & Oh, W. K. (2012) · Journal of Natural Products · doi:10.1021/np300258u · Cited by 42
NAD+ precursor supplementation in human ageing: clinical evidence and challenges
Vinten, K. T., Trętowicz, M. M., Coskun, E., van Weeghel, M., Cantó, C., Perez, R. Z., Janssens, G. E., & Houtkooper, R. H. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01387-7 · Cited by 44
“Nicotinamide adenine dinucleotide (NAD + ) is a versatile molecule that primarily functions as a coenzyme in cellular redox reactions, being converted to its reduced form (NADH) in fundamental metabolic processes such as glycolysis, fatty acid β-oxidation and the tricarboxylic acid cycle 1,2 .”
Self-citationYano, M., Akazawa, H., Oka, T., Yabumoto, C., Kudo-Sakamoto, Y., Kamo, T., Shimizu, Y., Yagi, H., Naito, A. T., Lee, J.-K., et al. (2015) · Scientific Reports · doi:10.1038/srep15857 · Cited by 39
The ADP-ribosyl cyclases - the current evolutionary state of the ARCs
Enza, M. F. (2014) · Frontiers in bioscience · doi:10.2741/4262 · Cited by 41
“The end result it that they all compete for NAD and this competition affects NAD homeostasis: PARP activation is reported to decrease intracellular NAD levels by 10-20% within minutes while the link between sirtuins and NAD levels is not so clear (81).”
BackgroundJang, S., Kim, E. W., Zhang, Y., Lee, J., Cho, S. Y., Ha, J.-H., Kim, H., & Kim, E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.068 · Cited by 42
Wang, J., Zhao, Z., Zhao, Y., Luo, G., Zhu, Z., Luo, Y., & Zhou, Y. (2019) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.9b03054 · Cited by 40
Fahlbusch, P., Knebel, B., Hörbelt, T., Barbosa, D. M., Nikolic, A., Jacob, S., Al‐Hasani, H., de Velde, F. V., Nieuwenhove, Y. V., Müller‐Wieland, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114144 · Cited by 40
“Further, the NAD+-dependent protein deacetylase sirtuin (SIRT) 1 plays a key role in hepatic glucose, fatty acid and energy metabolism.”
BackgroundInfluentialDoroftei, B., Ilie, O., Cojocariu, R.-O., Ciobica, A. S., Maftei, R., Grab, D., Anton, E., McKenna, J., Dhunna, N., & Simionescu, G. (2020) · Molecules · doi:10.3390/molecules25153323 · Cited by 41
“While the NRK1 receptor is widely distributed in the body, NRK2 is limited to the muscles, brain, and heart [28].”
BackgroundRapamycin maintains NAD+/NADH redox homeostasis in muscle cells
Zhang, Z., Xu, H. N., Li, S., Dávila, A., Chellappa, K., Davis, J. G., Guan, Y., Frederick, D. W., Chu, W., Zhao, H., et al. (2020) · Aging · doi:10.18632/aging.103954 · Cited by 44
van der Velpen, V., Rosenberg, N., Maillard, V., Teav, T., Chatton, J., Gallart‐Ayala, H., & Ivanisevic, J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15362 · Cited by 38
“…to impaired conversion from nicotinamide and/or NR) might significantly impact the replenishment of NAD+ also because the salvage pathways (including the PreissHandler pathway) are assumed to be the main source of NAD+, requiring the uptake of its precursors from the diet (Houtkooper et al., 2010).”
BackgroundExtracellular alpha-synuclein: Sensors, receptors, and responses
Domingues, R., Sant’Anna, R., da Fonseca, A. C. C., Robbs, B. K., Foguel, D., & Outeiro, T. F. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105696 · Cited by 41
Tipparaju, S. M., Li, X., Kilfoil, P. J., Xue, B., Uversky, V. N., Bhatnagar, A., & Barski, O. A. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1093-z · Cited by 40
“metabolically active tissues, such as the heart, brain, liver, and skeletal muscle, which maintain 100–300 μM NADPH in the cytosol [2, 10, 11], Kv1.”
BackgroundChung, H., & Joe, Y. (2014) · Integrative Medicine Research · doi:10.1016/j.imr.2014.09.005 · Cited by 40
Lifelong endurance training attenuates age-related genotoxic stress in human skeletal muscle
Cobley, J. N., Sakellariou, G. K., Murray, S., Waldron, S., Gregson, W., Burniston, J. G., Morton, J. P., Iwanejko, L. A., & Close, G. L. (2013) · Longevity & Healthspan · doi:10.1186/2046-2395-2-11 · Cited by 38
The emergence of the nicotinamide riboside kinases in the regulation of NAD+ metabolism
Fletcher, R. S., & Lavery, G. G. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0085 · Cited by 38
The function of nicotinamide phosphoribosyl transferase (NAMPT) and its role in diseases
Peng, A., Li, J., Xing, J., Yao, Y., Niu, X., & Zhang, K. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1480617 · Cited by 42
The role of mammalian sirtuins in cancer metabolism
Sebastián, C., & Mostoslavsky, R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.07.008 · Cited by 43
Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors
Wang, W., Elkins, K., Oh, A., Ho, Y., Wu, J., Li, H., Xiao, Y., Kwong, M., Coons, M. M., Brillantes, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109366 · Cited by 39
“Cancer cells are expected to be more sensitive to NAMPT inhibition than normal tissue due to their high metabolic requirement and increased dependence upon NAD consuming enzymes [14].”
BackgroundDegradation of Extracellular NAD+ Intermediates in Cultures of Human HEK293 Cells
Kulikova, V., Shabalin, K. A., Nerinovski, K., Yakimov, A. P., Svetlova, M., Solovjeva, L., Kropotov, A., Khodorkovskiy, M., Migaud, M. E., Ziegler, M., et al. (2019) · Metabolites · doi:10.3390/metabo9120293 · Cited by 39
Grolla, A. A., Miggiano, R., Marino, D. D., Bianchi, M., Gori, A., Orsomando, G., Gaudino, F., Galli, U., Grosso, E. D., Mazzola, F., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010571 · Cited by 40
Caloric restriction mimetics for the treatment of cardiovascular diseases
Sciarretta, S., Forte, M., Castoldi, F., Frati, G., Versaci, F., Sadoshima, J., Kroemer, G., & Maiuri, M. C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa297 · Cited by 41
Lahiri, T., Brambilla, L., Andrade, J., Askenazi, M., Ueberheide, B. M., & Levy, D. E. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12928 · Cited by 42
Vidugirienė, J., Leippe, D. M., Sobol, M., Vidugiris, G. J. A., Zhou, W., Meisenheimer, P. L., Gautam, P., Wennerberg, K., & Cali, J. J. (2014) · Assay and Drug Development Technologies · doi:10.1089/adt.2014.605 · Cited by 39
Chandrasekaran, K., Najimi, N., Sagi, A. R., Yarlagadda, S., Salimian, M., Arvas, M. I., Hedayat, A. F., Kevas, Y., Kadakia, A., & Russell, J. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094887 · Cited by 40
“5 mM range [66,67], which lies within the estimated Km values of SIRT1 for NAD+.”
BackgroundMehramiz, M., Porter, T., O’Brien, E. K., Rainey‐Smith, S. R., & Laws, S. M. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220088 · Cited by 41
“Sirtuins remove acetyl groups from lysines through NAD; therefore, they contribute to a wide range of physiological processes, including regulating gene expression, metabolism, and senescence [1].”
BackgroundInfluentialSuccinylation modification: a potential therapeutic target in stroke
Lian, J., Liu, W., Hu, Q., & Zhang, X. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382229 · Cited by 40
“There are studies reporting that miR-212-3p (Shang et al., 2021), miR-145-5p (Chang et al., 2021), miR-656-3p (Tang and Yang, 2020), miR-3677-3p (Tang and Yang, 2020), microRNA-19b (Sun et al., 2016) and miR-299-3p (Dang et al., 2018) can suppress SIRT5 expression.”
Visfatin as a therapeutic target for rheumatoid arthritis
Franco‐Trepat, E., Alonso‐Pérez, A., Guillán‐Fresco, M., Mora, A. J., Gualillo, O., Gómez-Reino, J. J., & Gómez, R. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1617274 · Cited by 38
Holper, L., Lan, M. J., Brown, P. J., Sublette, M. E., Burke, A. K., & Mann, J. J. (2019) · Depression and Anxiety · doi:10.1002/da.22913 · Cited by 38
“…to protect against mitochondria‐targeted neurotoxicity (Bachmann et al., 2009) thereby preserving or even enhancing mitochondrial function in general (X. Sun et al., 2006) and COX activity in particular (Bachmann et al., 2009; Cancelier et al., 2017; Hroudová & Fisar, 2010; Streck et al., 2015).”
Background
Metadata
- Authors
- Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- Laboratory for Integrative and Systems Physiology (R.H.H., C.C., J.A.), Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland;
- Amsterdam UMC Location University of Amsterdam (NL)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2010-04-01
- Volume
- 31
- Issue
- 2
- Pages
- 194-223
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2852209
- OpenAlex
- W2031050244
- Cited by
- 899
- References
- 251
- Citations by year
- 2026: 43 · 2025: 44 · 2024: 64 · 2023: 40 · 2022: 79 · 2021: 71 · 2020: 72 · 2019: 69 · 2018: 65 · 2017: 48 · 2016: 57 · 2015: 68 · 2014: 59 · 2013: 49 · 2012: 37
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A, 124713)
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-59820, P01DK059820)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- NAD+ metabolism, NAD+ signaling, NAD+-dependent deacetylase, poly(ADP-ribose) polymerase, redox signaling, transcriptional regulation, oxidative metabolism, lifespan extension, metabolic disorders
- MeSH terms
- Animals, Humans, Metabolic Diseases, NAD, Oxidoreductases, Transcription, Genetic, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.